Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2023 May 24:2023.05.24.542191. [Version 1] doi: 10.1101/2023.05.24.542191

Transcriptional Profiling and Genetic Analysis of a Cystic Fibrosis Airway-Relevant Model Shows Asymmetric Responses to Growth in a Polymicrobial Community

Christopher A Kesthely 1, Rendi R Rogers 1, Bassam El Hafi 1, Fabrice Jean-Pierre 1, George A O’Toole 1,*
PMCID: PMC10245937  PMID: 37293107

Abstract

Bacterial infections in the lungs of persons with cystic fibrosis are typically composed of multispecies biofilm-like communities, which modulate clinically relevant phenotypes that cannot be explained in the context of a single species culture. Most analyses to-date provide a picture of the transcriptional responses of individual pathogens, however, there is relatively little data describing the transcriptional landscape of clinically-relevant multispecies communities. Harnessing a previously described cystic fibrosis-relevant, polymicrobial community model consisting of Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus sanguinis and Prevotella melaninogenica, we performed an RNA-Seq analysis to elucidate the transcriptional profiles of the community grown in artificial sputum medium (ASM) as compared to growth in monoculture, without mucin, and in fresh medium supplemented with tobramycin. We provide evidence that, although the transcriptional profile of P. aeruginosa is community agnostic, the transcriptomes of S. aureus and S. sanguinis are community aware. Furthermore, P. aeruginosa and P. melaninogenica are transcriptionally sensitive to the presence of mucin in ASM, whereas S. aureus and S. sanguinis largely do not alter their transcriptional profiles in the presence of mucin when grown in a community. Only P. aeruginosa shows a robust response to tobramycin. Genetic studies of mutants altered in community-specific growth provide complementary data regarding how these microbes adapt to a community context.

Keywords: cystic fibrosis, Pseudomonas, Staphylococcus, Streptococcus, Prevotella, community, transcription, mutants

Introduction

Cystic fibrosis (CF), caused by a mutation in the CF transmembrane conductance regulator (CFTR) gene (1), is the most common autosomal recessive genetic disease in Caucasian populations (2). Mutations in CFTR have been demonstrated to impair the function of many organ systems, including the lungs. One of the hallmarks of disease for persons with CF (pwCF) is a loss of chloride channel function, resulting in increased mucous viscosity, reduction in mucociliary clearance and accumulation of mucus on the epithelial surface of the airways (35). The reduction of mucus clearance in the lungs of pwCF provides an ideal environment for the growth of bacterial and fungal pathogens; these chronic infections increase inflammation, resulting in tissue damage and increased mortality rates (6, 7).

Chronic infections originate early in the lives of pwCF (8). Once infected, many of the microbes that colonize the lungs of pwCF transition from an acute infection to a chronic biofilm mode of growth (913). The development of chronic infections in pwCF is associated with poor clinical outcomes, with 80–95% of pwCF succumbing to respiratory failure associated with chronic bacterial infections and the associated airway inflammation (14).

Examination of human infections with microscopy revealed the polymicrobial nature of many infections (1517). Despite early knowledge that many infections are associated with more than one microbe, most efforts have focused on the study and treatment of individual bacterial species (15). Research focusing on polymicrobial communities has found that when multiple bacterial genera/species are present in a community, there is a disconnect between culture-based antimicrobial susceptibility testing and clinical responses (1820).

Recent work from our lab has attempted to reconcile our lack of knowledge regarding polymicrobial biofilms in the context of CF infections (21). Our work has focused on a new clinically-informed model community comprised of a set of four CF-relevant microbes: Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus sanguinis and Prevotella melaninogenica, grown in artificial sputum medium (ASM) under anoxic conditions, mimicking the nutritional environment found in the mucus associated with the lungs of pwCF (2126).

In this study, we developed transcriptional profiles of the four constituent members of a four-microbe community in a clinically-relevant growth condition, both in monoculture, in the four-microbe community, and in response to several perturbations. This data set will serve as a resource for the community. A key finding of these analyses is the differential impact on the transcriptome for these microbes grown in monoculture versus co-culture. We also performed genetic screens showing that a microbe with little change in transcription in the community (P. aeruginosa) also yield few mutants with small effect sizes in the community context. In contrast, for two microbes showing marked changes in the community transcriptome, we identified multiple mutants, some with large effect sizes. The transcriptional and genetic studies support the conclusion that microbes display asymmetric responses to growth in a polymicrobial community.

Results and Discussion

Transcriptional profiling studies

We performed a series of transcriptional profiling studies to better understand genes differentially expressed in monoculture versus our previously reported, clinically-relevant multispecies community (24). We also assessed the transcriptional profile of the community upon treatment with tobramycin in fresh medium (using fresh medium as a control), in medium lacking mucin, and for a community including a common P. aeruginosa variant frequently detected in the CF airway, that is, a ∆lasR mutant. We previously reported that LasR defective strains show an increased tolerance to tobramycin in the mixed community (24).

To this end, we obtained transcriptional profiles of each of the four constituent species, P. aeruginosa PA14, S. aureus Newman, S. sanguinis SK36 and P. melaninogenica ATCC 25845, across the different growth conditions outlined above (Table 1, Supplemental Tables 14). Co-culturing these four microbes in ASM supplemented with mucin provides a means to mimic the nutritional, environmental and community composition common in the CF airway (2326), providing an ideal in vitro model to examine the transcriptional landscape of these four microbes in CF-relevant growth conditions.

Table 1.

Labels for the strains and growth conditions used in the transcriptional studies.

Growth Condition Strain(s) Growth Condition
PA14 P. aeruginosa PA14 24h in ASM
S. aureus S. aureus Newman 24h in ASM
S. sanguinis S. sanguinis 24h in ASM
lasR P. aeruginosalasR 24h in ASM
Mix P. aeruginosa, S. aureus, S. sanguinis, P. melaninogenica 24h in ASM
Mix_∆lasR P. aeruginosalasR, S. aureus, S. sanguinis, P. melaninogenica 24h in ASM
Mix_base P. aeruginosa PA14, S. aureus, S. sanguinis, P. melaninogenica 24h in ASM base (no mucin added)
Mix_∆lasR_swap P. aeruginosalasR, S. aureus, S. sanguinis, P. melaninogenica 24h growth in ASM, fresh medium added for 15min
Mix_∆lasR_tob P. aeruginosalasR, S. aureus, S. sanguinis, P. melaninogenica 24h growth in ASM, fresh medium with 100 μg/ml tobramycin added for 15min
Mix_swap P. aeruginosa PA14, S. aureus, S. sanguinis, P. melaninogenica 24h growth in ASM, fresh medium added for 15min
Mix_tob P. aeruginosa PA14, S. aureus, S. sanguinis, P. melaninogenica 24h growth in ASM, fresh medium with 100 μg/ml tobramycin added for 15min

Response of the microbes to growth in the community

To begin analyzing our data, each genus’ RNA profiles in each of the indicated growth conditions were used to produce a series of PCA plots (Figure 1 AE). Each point shown in the PCA plots represents the first two principal components for an individual biological replicate for the indicated condition, each with 4 replicates. We observed that P. aeruginosa and the ∆lasR mutant monocultures (Figure 1A, Mono and ∆lasR, respectively) clustered with their community-grown counterparts (Figure 1A, Mix and Mix_ ∆lasR, respectively). In contrast, the S. aureus monoculture (Figure 1B, Mono, pink) and S. sanguinis monoculture (Figure 1C, Mono, pink) were distinct from their corresponding community-associated counterparts (Mix, red). As previously reported, Prevotella does not grow in the model in monoculture (24) so there is no “Prevotella monoculture” condition (Figure 1D). The key for Figures 1AD is shown in Figure 1E.

Figure 1. Variation in transcriptional profiles of monoculture versus the four-microbe community (Mix) in different culture conditions.

Figure 1.

A. PCA plot of P. aeruginosa transcriptional profiles across all culture conditions containing P. aeruginosa. B. PCA plot of S. aureus transcriptional profiles across all culture conditions containing S. aureus. C. PCA plot of S. sanguinis transcriptional profiles across all culture conditions containing S. sanguinis. D. PCA plot of P. melaninogenica transcriptional profiles across all culture conditions containing P. melaninogenica. The gene lists used to generate the diagrams in panels A-D can be found in Supplemental Table 14. E. Legend for the PCA plots in panels A-D. F. A distance matrix comparing the mixed community (Mixed) to the mean point for each of the other conditions (see Table 1) displayed in each PCA plot. Values were calculated via Euclidean distance between means and are included in the respective value marker present with each distance heatmap.

We performed a PERMANOVA on the data associated with each of the PCA plots to determine if the groupings were significantly different from each other. Pairwise tests demonstrated that only groupings within the P. aeruginosa PCA were classified as significantly different from each other. Specifically, while there was no significant difference for the WT or the lasR mutant in monoculture or the mixed community, or the Wt or lasR communities exposed to tobramycin, we did observe a significant difference when mucin was removed from the medium. For all other PCA plots shown in Figure 1, while we do see some significant changes in gene expression in response to perturbations, the overall transcriptional profiles are not statistically significant by PERMANOVA.

As a first step, the transcriptional data were compared using the mixed community (Mix) growth condition as a baseline to compare to the monoculture condition. P. aeruginosa wild type (WT) monocultures were found to have 19 downregulated genes and 135 upregulated genes when compared to the polymicrobial biofilm (Supplemental Table 1). Of the 135 genes upregulated in the P. aeruginosa WT monospecies biofilms, many of these genes are in pathways and/or operons implicated in biofilm formation and quorum sensing (Supplemental Table 1).

S. aureus monocultures showed 50 downregulated genes and 159 upregulated genes when compared to S. aureus grown in the polymicrobial biofilm (Supplemental Table 2). Of the 50 downregulated genes, a large portion are implicated in metabolism and amino acid synthesis, while of the 159 upregulated genes, there is an enrichment for genes involved in S. aureus quorum sensing and thymidine metabolism (Supplemental Table 2).

S. sanguinis monocultures showed 240 downregulated genes and 211 upregulated genes when compared to S. sanguinis grown in the polymicrobial biofilm (Supplemental Table 3). The 240 downregulated genes were enriched for pathways involved in amino acid synthesis and D-xylulose-5-P synthesis, while the 211 upregulated genes were enriched for pathways involved in catabolism and metabolism (Supplemental Table 3).

Although the S. aureus, S. sanguinis and P. aeruginosa cultures appear to have a similar number of differentially regulated genes, the proportion of differentially regulated genes, in relation to genome size and number of genes, is less by a factor of two for P. aeruginosa compared to either S. aureus or S. sanguinis. Additionally, a closer examination of the magnitude of differential gene expression between the monocultures and co-cultures were lower for P. aeruginosa than for S. aureus or S. sanguinis. P. aeruginosa monocultures differed from the multispecies cultures by a log2FC of −2.87 – 5.32, the magnitude of differential gene expression of S. aureus monocultures differed from the multispecies cultures by a log2FC of −7.55 – 9.38 and S. sanguinis cultures differed by a log2FC of −11.10 – 7.56.

To further compare the transcriptional differences between the various conditions used in this study, we produced a distance matrix comparing the mixed community (Mix) to the mean point for each of the other conditions displayed in each PCA plot (Figure 1F). This distance matrix reinforces the finding that that P. aeruginosa (WT and the ∆lasR mutant) shows a modest shift in overall transcriptional profile when grown in monoculture versus mixed culture. Thus, it appears that P. aeruginosa is somewhat agnostic, in terms of gene expression, to monoculture growth conditions versus growth in the polymicrobial community. In contrast, the relative shift in transcriptional profiles for S. aureus and S. sanguinis in monoculture is much more striking when compared to growth in the mixed community (Figure 1F).

Impact of fresh medium and tobramycin on transcriptional profiles

In a previous study, we found that the polymicrobial biofilm community conferred tolerance to tobramycin for biofilm-grown S. aureus and S. sanguinis compared to their planktonic counterparts (24). For S. aureus, growth in the mixed community conferred a modest (1-log) higher viability when exposed to tobramycin, while for S. sanguinis, growth in a mixed community resulted in 8-log greater viability than in the pure culture when both were exposed to tobramycin. In contrast, there was a statistical increase in the viability of the S. sanguinis, and no change to S. aureus when grown in mixed community when compared to the monoculture in the absence of tobramycin (24). Further, community-grown P. melaninogenica biofilms were unaltered by the presence or absence of tobramycin in the mixed community (Supplemental Table 4) (24). Unexpectedly, our previous work found a decrease in viability of biofilm-grown P. aeruginosa in the mixed community following the addition of tobramycin; this phenotype was reversed for the P. aeruginosa lasR mutant strain (24). We explore the impact of the lasR mutation below.

To better understand the basis of these changes in tolerance for microbes grown in the absence versus presence of the other community members (24), we assessed the transcriptional profiles of each of the constituent members of the four-microbe community upon the addition of fresh medium with tobramycin or fresh medium alone as the control. To assess the acute effects of addition of tobramycin, we harvested RNA 15 minutes after antibiotic (or medium control) exposure. We hypothesized that a 15-minute incubation would be sufficient to alter the transcriptional profiles without a significant loss in bacterial viability, which we confirmed experimentally (Supplemental Figure 1). The relatively short turnover time of mRNAs in bacteria (27, 28) supports our ability to investigate the acute effects of exposure to tobramycin.

We analyzed the response to acute tobramycin exposure versus the medium control in two ways. First, we generated a series of heatmaps to visualize the 50 most variably expressed genes (Figure 2) across all growth conditions in each tested species (Table 1). The list of these 50 genes is shown in Supplemental Table 5. The differentially expressed genes for the tobramycin exposure (Mix_tob, in brown) and the medium control (Mix_swap, in yellow, because the medium was “swapped”) formed a tight cluster for WT P. aeruginosa and for the lasR mutant, discrete from all other conditions– all other conditions were grown for 24 hours without the addition of fresh medium (Figure 2A). The tight association of the profiles of the top differentially expressed genes for the tobramycin exposure (Mix_tob) and the medium control (Mix_swap) are also reflected in the tight clustering of the respective samples in the P. aeruginosa PCA plot (Figure 1A).

Figure 2. Heatmaps depicting the 50 most differentially expressed genes for each of the four bacteria present in monoculture and mixed communities in the different culture condition.

Figure 2.

A. The top 50 genes that are differentially expressed among the 9 different P. aeruginosa growth conditions. B. The top 50 differentially expressed genes in the 8 different S. aureus growth conditions. C. The top 50 differentially regulated genes in the 8 different S. sanguinis growth conditions. D. The top 50 differentially regulated genes in the 7 different P. melaninogenica growth conditions. Variation in gene expression was calculated with the rowVars function in the matrixStats package in R. The mean expression across all growth conditions was calculated, and the difference between the individual growth condition and the mean was utilized to produce a heatmap depicting the most differentially expressed genes across our various growth conditions through the use of the pheatmap package in R. The gene lists used to generate these diagrams can be found in Supplemental Table 5.

To further illustrate the influence of fresh medium +/− tobramycin on the mixed communities, a series of Venn diagrams were created to show the numbers of genes differentially expressed in these conditions compared to the mixed cultures at 24 hours (Figure 3). To generate the gene lists used to produce the Venn diagrams (Supplemental Tables 69), the RNA-Seq data were filtered to select only genes with a |log2FC| > 1.5 and an adjusted p-value < 0.05, then comparing samples exposed to only fresh medium to those exposed to fresh medium plus 100 μg/ml tobramycin.

Figure 3. Genes differentially expressed from the mixed community (Mix) growth condition.

Figure 3.

Venn Diagrams were created to depict the number of genes differentially regulated in each of the growth conditions when compared to the mixed community grown in ASM (Mix) for A. P. aeruginosa, B. S. aureus, C. S. sanguinis and D. P. melaninogenica. To be included in the plot, genes had to be statistically differentially expressed (p < 0.05) and have a log2 fold change greater than or equal to the absolute value of 1.5. To provide a more informative figure, genes that were up and downregulated in comparison to the Mix biofilm condition were separated into separate Venn diagrams, left and right, respectively. Further analysis focused on the intersection of all datasets to elucidate the influence of fresh medium, and the intersection of solely the tobramycin conditions to elucidate the influence of tobramycin on the biofilm. The gene lists used to generate these diagrams can be found in Supplemental Tables 69.

Each of the Venn diagrams in Figure 3 consist of 15 different regions. For P. aeruginosa, this analysis revealed a total of 47 upregulated and 93 downregulated genes associated with addition of fresh medium, and an additional 193 upregulated and 107 downregulated genes in response to tobramycin treatment (Supplemental Table 6). These differentially regulated genes were dominated by genes implicated in various metabolic pathways. Thus, P. aeruginosa showed a robust transcriptional response to the addition of tobramycin independent of the effect of adding fresh medium in the mixed community (Figure 1F).

The three other constituent members of the polymicrobial community showed a minimal response to the presence of tobramycin in the heatmap analysis of the top 50 genes, but their response to the addition of fresh medium was robust (Figure 1BF, Figure 2BD, Supplemental Table 79). This observation is best illustrated in Figure 2BD by the co-clustering of samples exposed to fresh medium and fresh medium plus tobramycin for the WT and ∆lasR mutant communities. In contrast, for P. aeruginosa and as detailed above, the samples from cultures exposed to fresh medium formed a discrete cluster from those cultures exposed to fresh medium plus tobramycin (Figure 2A). The lack of a transcriptional response for S. aureus and P. melaninogenica is consistent with our previous report that these microbes do not show a robust change in the viability of biofilm-grown bacteria in monoculture versus a mixed community when exposed to tobramycin (24).

Interestingly, despite its lack of transcriptional response to tobramycin treatment, S. sanguinis biofilms treated with tobramycin do show a large and significant shift in viability when grown as a monoculture as compared to a mixed community (24). This change in behavior may be due to non-transcriptional mechanisms and/or response(s) to tobramycin that occur after the 15-minute exposure used in this study, or may be due to an unknown polymicrobial interaction protecting the S. sanguinis from tobramycin. The differential expression of genes in P. aeruginosa, but not the other three species in the polymicrobial community upon the addition of tobramycin to the cultures is consistent the modest efficacy of tobramycin in removal of Pseudomonas from the lungs of pwCF, however, does not provide insight into to reducing the remaining community members.

The transcriptional response to the exposure to fresh medium, independent of the exposure to tobramycin, for S. aureus, S. sanguinis and P. melaninogenica, is illustrated by the separation of the datapoints for these three microbes in the PCA plots in Figure 1, Venn diagrams in Figure 3 and Supplemental Tables 79. As expected, the addition of fresh ASM, whether with or without tobramycin, drastically altered the transcriptional profiles of each species in the community (2931). An analysis of the transcriptional responses of each of these species upon the addition of fresh medium failed to uncover any specific pathways. That is, many of the differentially regulated genes belonged to the “carbon metabolism” or “microbial metabolism in diverse environments” pathways as assessed by KEGG pathway analysis.

Impact of the lasR mutation on transcriptional profiles

As mentioned above, we previously showed a substantial decrease in viability of biofilm-grown P. aeruginosa in the mixed community following the addition of tobramycin; this phenotype was reversed for the P. aeruginosa lasR mutant strain (24). Therefore, we included the ∆lasR mutant in several conditions: in monoculture, in the mixed community, in the mixed community exposed to fresh medium +/− tobramycin.

For P. aeruginosa, as expected, the top differentially expressed genes for the WT and the ∆lasR mutant formed discreet clusters (Figure 2A), whether grown in monoculture or in the mixed community for 24 hrs or exposed to fresh medium +/− tobramycin.

In contrast, S. aureus mixed cultures or the cultures exposed to fresh medium +/− tobramycin were unaffected by the P. aeruginosalasR mutant, which can be observed in PCA plot in Figure 1B and by the overlap of the most variably expressed genes in Figure 2B. Similarly, S. sanguinis appears to be agnostic to the presence of a P. aeruginosalasR mutant as the transcriptional profile of this microbe in the mixed community with WT P. aeruginosa and mixed community with the ∆lasR mutant are co-mingled in PCA plots (Figure 1C) and by clustering (Figure 2C). Finally, the ∆lasR mutant does not appear to impact the transcriptome of P. melaninogenica, as the profiles of this anaerobe grown with the WT and ∆lasR mutant are intermixed in the PCA plot (Figure 1D) and by clustering (Figure 2D). Overall, while loss of LasR function impacts the transcriptome of P. aeruginosa, as expected (3234), mutating this quorum sensing system has a minimum impact on the other microbes in the community in the time frame used in our study.

Impact of mucin on transcriptional profiles

The polymicrobial biofilms of both P. aeruginosa and P. melaninogenica are impacted by the presence or absence of mucin, while the S. aureus and S. sanguinis cultures show a minimal response to the presence/absence of mucin. Previous work demonstrated that bacteria like P. melaninogenica play a large role in mucin degradation (35, 36). Even though S. sanguinis has previously been shown to play a role in mucin degradation (35, 37, 38), we did not observe a transcriptional response indicating differential gene regulation when comparing Mix_base (no mucin) growth condition to the Mix growth condition (i.e., with mucin added).

As mentioned above, mucin degradation is associated with fermentative anaerobes such as P. melaninogenica (35). The fermentation of mucin by P. melaninogenica generates acetate and propionate, on which P. aeruginosa is partially dependent for growth in bacterial communities that mimic the lower airway of pwCF (35). In this work, the downregulation of prpR, which codes for the propionate catabolism regulator, in P. aeruginosa grown in the absence of mucin points to the bioavailability of propionate produced by P. melaninogenica in the presence of mucin. Likewise, a decrease in P. melaninogenica HMRPREF0695_A6215 transcription, coding for acetate kinase, which is responsible for the production of acetate and propionate, in the Mix_base (-mucin) community when compared to the Mix community (+mucin) points to a change in the metabolic profile of P. melaninogenica when grown in the mixed community in the absence of mucin.

Summary of transcriptional responses

To further explore the transcriptional variability in each of the strains in the community, and across each growth condition, an upset plot was created for each bacterial species to compare the number of co-regulated genes across each of the growth conditions (Table 1) using the mixed community (Mix) as the comparison condition (Figure 4). The large number of co-regulated genes that were differentially regulated in similar conditions across each of our upset plots demonstrates the robustness of our dataset. To visualize the changes in how the transcriptional profiles changed across the various growth conditions, up and downregulated genes were separated to better understand how the transcriptional profiles of each organism was affected by the various growth conditions tested herein.

Figure 4. Upset plots to depict the number of differentially regulated genes.

Figure 4.

Upset plots were created to depict the number of genes differentially regulated in each of the growth conditions for both up and downregulated genes when compared to the mixed community grown in ASM (Mix). All genes used in the production of this plot were statistically differentially expressed (p < 0.05) with a log2 fold change greater than or equal to the absolute value of 1.5.

Figure 4 demonstrates the roles that mucin and fresh medium have on the communities. With the exception of S. sanguinis, the lack of mucin produced the most differentially regulated genes in each of the other species across all of the treatments tested. The complexity of the mucin may play a role in secondary metabolism in each of these other microbial species. Since the human host produces 22 different mucins, it is also possible that the composition of the available mucin could play a role in the metabolism and interspecies interactions between each of the bacteria in our polymicrobial model (39, 40). Fresh medium, as described above, also plays a large role in the transcriptional profiles of each member of the tested polymicrobial communities. The large number of differentially regulated genes in the samples containing fresh medium support the ability of these bacteria to rapidly alter their transcription in responses to the presence of fresh nutrients.

How genetic studies correlate with the transcriptional analyses

To complement the transcriptional analysis presented here, we performed genetic screens to ascertain the genes that, when mutated, would reduce survival in the community compared to monoculture, and at what magnitude (Figure 5). Genetic screens were performed with P. aeruginosa, S. sanguinis and S. aureus mutant libraries (4143), and we compared viability of each mutant (via CFUs) when grown in polymicrobial community versus in monoculture.

Figure 5. Fold change of mutants identified in genetic screens.

Figure 5.

Genetic screens using non-redundant transposon libraries were used to screen for mutations that reduced the growth of microbes in the polymicrobial community versus monoculture. A. Mutants that impacted the growth if P. aeruginosa (left) and S. sanguinis (right) when grown in the four-microbe community compared to monoculture. B. Mutants of P. aeruginosa that altered the growth of P. melaninogenica when grown as a co-culture. To be included, mutants had to decrease the CFUs of the strain from those grown in the monoculture, A, or when compared to P. melaninogenica grown in the presence of WT P. aeruginosa by ≥1-log. B. All mutants here showed no defect in monoculture growth (not shown). Stats were performed using both a wilcox test and with the ggsignif package in R. p=0.0078.

For the full P. aeruginosa transposon library (~4500 mutants in non-essential genes), only 5 mutants were isolated; all of these strains resulted in a modest 1-log loss in CFU in the polymicrobial community as compared to when the mutant was grown in monoculture.

Following the same procedures, screening the whole S. sanguinis transposon library (~2100 mutants) yielded 34 genes with reduced CFU when mutants were grown in a mixed community compared to a monoculture. When compared with the five genes that restricted the growth of P. aeruginosa in the community, these 34 genes produced a significantly larger log-fold change (Figure 5A, right side), varying from 1-log to 3.5-log fold change in viability. Interestingly, screening half of the S. aureus Newman transposon library (~1500 mutants) did not yield mutants with reduced viability when grown in the community.

Due to the lack of genetic tools in P. melaninogenica, and its inability to grow as a monoculture in ASM, we focused on P. aeruginosa mutants that limited the growth of P. melaninogenica in co-culture compared to co-culture with WT P. aeruginosa. The genetic screen of ~4500 mutants from the P. aeruginosa mutant library identified 15 P. aeruginosa mutants that impacted the growth of P. melaninogenica (Figure 5B). Thirteen of the P. aeruginosa mutations provided ~1-log fold change in the growth of P. melaninogenica, while two mutants abolished the ability of P. melaninogenica to grow in co-culture conditions. All of the transposon mutants identified here grew as well as the WT strain in mono- and co-culture.

Together, the genetic analysis largely mirrors the transcriptional study, that is, P. aeruginosa, which is agnostic to community growth yielded few mutants with small effects on viability in the community. In contrast, for S. sanguinis and P. melaninogenica, which showed a more robust transcriptional response to growth in the community, also yielded more mutants with a larger range of phenotypes. The one exception was S. aureus, which despite its robust transcriptional responses across the various conditions analyzed here, failed to yield any mutants that showed a defect specific to the community, perhaps suggesting that S. aureus is well suited to compete against other microbes in a community via redundant systems not accessible to genetic screens.

Conclusions

Our findings indicate that in the model polymicrobial community, the transcriptional profile of P. aeruginosa remains relatively unchanged by the presence of the other members of our community, a finding reflected by the genetic analysis. That is, both experimental approaches used here reiterate capacity of P. aeruginosa to thrive in the presence of other microbes across a range of environments. In contrast, the transcriptional profiles of the other members of the community are influenced by each other and environmental perturbations. Again, the transcriptional analysis is largely reflected by our genetic studies, with the exception of S. aureus.

While a great deal of work has focused on P. aeruginosa monospecies biofilms, and the role of the transcriptional regulator LasR impacting the transcription of hundreds of genes in this microbe (4449), our findings indicate that a ∆lasR mutant of P. aeruginosa had a negligible influence on the transcriptional profiles of the other members of the community.

As expected, the addition of fresh medium, both with and without tobramycin, drastically altered the transcriptional responses of each of the members of the polymicrobial community. However, surprisingly, the addition of tobramycin only altered the acute transcriptional response of P. aeruginosa. The lack of a transcriptional response to tobramycin by the other members of this community confirms previous work performed in our lab demonstrating that upon tobramycin treatment, the viability of S. sanguinis, S. aureus and P. melaninogenica largely remain unchanged when grown in the polymicrobial community (24).

Here we have generated and performed an initial transcriptional analysis of a model polymicrobial community relevant to CF. We hope that providing the complete dataset to the broader research community will stimulate further hypotheses and help to advance the treatment of polymicrobial infections in CF-relevant infections. Due to the complexity of many polymicrobial infections, we believe that we have established a framework to further investigate polymicrobial infections using an approach that enables hypothesis generation, while simultaneously implicating specific genes and pathways for their roles in complex microbe-microbe interactions.

Materials and Methods

Bacterial strains and culture conditions.

Pseudomonas aeruginosa PA14, Staphylococcus aureus Newman, Streptococcus sanguinis SK36 and Prevotella melaninogenica ATCC 25845 used in this study are listed in Table 1. All strains were cultivated as previously described (24). Briefly, P. aeruginosa and S. aureus cultures were grown in Tryptic Soy Broth (TSB) with shaking at 37°C. P. melaninogenica cultures were grown in TSB supplemented with 0.5% Yeast Extract (YE), 5 µg/mL hemin, 2.85 mM L-cysteine hydrochloride and 1 µg/mL menadione (Prevotella growth medium – PGM). S. sanguinis overnight cultures were grown in Todd-Hewitt Broth supplemented with 0.5% YE (THY) at 37°C with 5% CO2. Artificial sputum medium with (ASM) or without mucin (ASM base) was prepared as previously reported (24) and supplemented with 100 mM 3-morpholinopropane-1-sulfonic acid (MOPS) to maintain a pH of 6.80.

Microbial growth assays.

Culture experiments were performed as previously described by (24) with modifications. Briefly, cells from overnight liquid cultures of P. aeruginosa, S. aureus, S. sanguinis and P. melaninogenica were individually collected and washed twice (for P. aeruginosa and S. aureus) or once (for S. sanguinis and P. melaninogenica) in sterile Phosphate-Buffered Saline (PBS) by centrifuging at 10,000 x g for 2 minutes. After the final wash, cells were resuspended in ASM base. The optical density (OD600) was then measured for each bacterial suspension and diluted to an OD600 of 0.2 in either ASM or ASM base, depending on the subsequent growth condition. Monocultures and co-cultures were prepared from the OD600 = 0.2 suspensions and further diluted to a final OD600 of 0.01 for each microbe in ASM or ASM base, depending on the subsequent growth condition. Per each monoculture and co-culture conditions, a full polystyrene flat-bottom 96-well plate was inoculated with 100 µl of bacterial suspension. Plates were incubated using an AnaeroPak-Anaerobic container with a GasPak sachet (ThermoFisher) at 37 °C for 24 hours. After incubation, plates were processed and split into three separate groups. For group 1, which included monocultures and co-cultures communities grown in ASM or ASM base, unattached cells were aspirated with a multichannel pipette. Pre-formed biofilms were then washed once with sterile PBS and resuspended in 50 µl of RNAprotect (Qiagen) using a sterile 96-pin replicator. For the remaining groups (co-culture communities with WT or ΔlasR P. aeruginosa), plates were anaerobically transferred from an AnaeroPak-Anaerobic container with a GasPak sachet to an anoxic environmental chamber (Whitley A55 - Don Whitley Scientific, Victoria Works, UK) with 10% CO2, 10% H2, 80% N2 mixed gas at 37 °C. Unattached cells of co-culture communities grown in ASM were aspirated with a multichannel pipette and 100 µl of either fresh ASM (group 2) or ASM supplemented with 100 µg/mL tobramycin (group 3), was added to the pre-formed biofilms for 15 minutes. After incubation, the supernatants were removed and the biofilms were washed once with sterile PBS. For all groups, a volume of 50 µl of RNAprotect was added to the biofilms and collected using a sterile 96-pin replicator. For all conditions, a control plate of the monocultures and co-cultures was 10-fold serially diluted and plated on selective media, as previously reported (24), as a control to confirm the expected viable counts of bacteria grown under each condition.

RNA purification, sequencing and analysis.

Following growth and collection of biofilms in RNAprotect, bacterial lysis and RNA extraction were performed following the protocols outlined in the RNeasy Mini Kit (Qiagen). Because of S. aureus in the mixed communities, cells lysis conditions included a combination of lysozyme (800 μg/ml) and lysostaphin (12.5 μg/ml). The concentration and quality of the RNA was checked on a Nanodrop 2000 (Thermo) prior to sending the samples for library preparation and sequencing (SEQCENTER). Briefly, samples were DNase treated (Invitrogen) prior to library preparation using the Illumina Stranded Total RNA Prep Ligation with Ribo-Qero Plus kit and 10 bp IDT for Illumina indices. Sequencing was performed on a NextSeq 2000 (2 × 51 bp reads). SEQCENTER performed demultiplexing, quality control and adapter trimming with bcl-convert (v3.9.3) (50). Upon obtaining the data, samples were subsequently analyzed with Cutadapt (51) to a phred score of 20, a minim length of 10 bp and using Cutadapt’s nextseq-trim function set at 10. Sequencing reads were mapped to the P. aeruginosa PA14 genome (NC_008463.1), S. aureus Newman genome (NC_009641.1), S. sanguinis SK36 genome (NC_009009.1) or the P. melaninogenica ATCC 25845 genome (NC_014370.1 and NC_014371.1) using bowtie2 (52) in paired end read using default parameters. The sam files were converted to sorted.sam files using samtools (53) prior to using featureCounts (54)with default parameters to calculate reads per gene. The differential expression of genes in each condition was determined through the use of DEseq2 (55). Read counts were normalized using the estimateSizeFactors function. Genes with read counts under 10 were dropped from our dataset. The biological coefficient of variance was estimated, and a linear model was fit to determine the differential expression of genes between samples. Our false discovery rate was adjusted from p-values using the Bonferroni correction (56). To compare the transcriptional profiles between samples, our datasets were further filtered to ensure that only genes with a differential expression by a log2 fold change (logFC) threshold greater than the absolute value of 1.5 and an adjusted p-value less than 0.05 were used in our downstream analyses. PCA plots were produced in base R, while heatmaps utilized the ComplexHeatmap (57) and pheatmap (58) R packages. Venn diagrams and upset plots were produced with the VennDiagram (59) and ggupset (60) R packages respectively.

Genetic screens.

For the genetic screens, we utilized non-redundant transposon mutant libraries for each of P. aeruginosa PA14, S. sanguins SK36 and S. aureus Newman (4143). Overnight liquid cultures of mutant libraries were grown in polystyrene flat-bottom 96-well plates with each well containing a different mutant growing in 100uL of TSB for P. aeruginosa, THY for S. sanguinis and TSB+YE for S. aureus Newman. The 96 well plates containing monoculture conditions and co-culture conditions in ASM with S. aureus, S. sanguinis, and P. melananogenica were prepared using methods described above and inoculated with 1–2 uL of the P. aeruginosa PA14 (41), S. sanguinis (42) and S. aureus Newman (43) mutant libraries using a 96-pin replicator.

For all screens, plates were incubated using an AnaeroPak-Anaerobic container with a GasPak sachet (ThermoFisher) at 37 °C for 24 hours. After incubation, unattached cells were aspirated with a multichannel pipette. Pre-formed biofilms were then washed once with sterile PBS. Cells were then resuspended in 50 µl PBS and spotted onto the appropriate selective medium for each microbe using a sterile 96-pin replicator, as previously reported (24). Mutants that showed confluent growth in the monoculture condition but little to no growth in the mixed condition were selected as candidates for re-testing. For confirmation, each candidate was grown in triplicate in the monoculture and mixed conditions as described above. After incubation, all cultures were 10-fold serially diluted and plated on PIA for P. aeruginosa, SSA from S. sanguinis, TSB for S. aureus, or TSB+YE for P. melaninogenica to quantify cell counts by colony forming units (CFUs), as reported.

Statistical Analyses.

All statistical analyses performed in this paper were done in R. Principal component analyses (PCA) were performed on normalized and log transformed count data obtained from a DESeq2 analysis performed on the read counts for each of the 4 RNA-Seq replicates analyzed in this paper.

The adonis2 function from the package Vegan (61) was utilized to compare the overall dataset, and found a significant difference between each strain (p<0.001 for all four species tested). To examine pairwise groupings between the various strain groupings in the PCA plots (Figure 1AD), we utilized the pairwise.adonis function from the package Vegan (61, 62). Analyses were performed using the PC1 and PC2 data for each respective species, and comparisons made between each of the respective growth conditions. Both the adonis 2 and pairwise.adonis analyses utilized Euclidean distances as the “method”, or “sim.method” variable, respectively, to remain consistent with the Euclidean distances that were calculated to compare groupings in Figure 1F.

To compare the P. aeruginosa and S. sanguinis screen data, p-values were calculated through the use of the wilcox.test function, and the ggsignif package in R (63). Due to the difference in how the screen data were generated for P. aeruginosa, S. aureus, S. sanguinis and the P. melaninogenica samples, statistical analysis was not done to compare the P. melaninogenica data to the P. aeruginosa and S. sanguinis data.

Supplementary Material

Supplement 1
media-1.xlsx (1.6MB, xlsx)
Supplement 2
media-2.xlsx (716.1KB, xlsx)
Supplement 3
media-3.xlsx (572.1KB, xlsx)
Supplement 4
media-4.xlsx (512KB, xlsx)
Supplement 5
media-5.xlsx (29.7KB, xlsx)
Supplement 6
media-6.xlsx (21.5KB, xlsx)
Supplement 7
media-7.xlsx (15.4KB, xlsx)
Supplement 8
media-8.xlsx (13.8KB, xlsx)
Supplement 9
media-9.xlsx (14.4KB, xlsx)
Supplement 10
media-10.pdf (162.7KB, pdf)

Importance.

Polymicrobial infections constitute the majority of infections in the cystic fibrosis (CF) airway, but their study has largely been neglected in a laboratory setting. Our lab previously reported a polymicrobial community that can explain clinical outcomes in the lungs of persons with CF. Here we obtain transcriptional profiles of the community versus monocultures to provide transcriptional information about how this model community responds to CF-related growth conditions and perturbations. Genetic studies provide complementary functional outputs to assess how the microbes adapt to life in a community.

Acknowledgements.

This work was supported by Cystic Fibrosis Foundation (JEAN21F0) to FJP and National Institutes of Health (R01 AI155424) to GAO. We would like to thank Dr. Tom Hampton and the DartCF core (NIH grant P30 KD117469 and CFF grant STANTO19R0) for conversations regarding data analysis.

Footnotes

Data availability statement. Raw sequencing data was submitted as an SRA to NCBI and is available under the BioProject accession PRJNA971914. UNIX and R code used to produce the data and figures presented in this paper are available on GitHub (https://github.com/GeiselBiofilm).

References

  • 1.Riordan JR, Rommens JM, Kerem BS, Alon NOA, Rozmahel R, Grzelczak Z, Zielenski J, Lok SI, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS, Tsui LC. 1989. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA. Science 245:1066–1073. [DOI] [PubMed] [Google Scholar]
  • 2.Mehta G, Macek M, Mehta A. 2010. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. Journal of Cystic Fibrosis 9:S5–S21. [DOI] [PubMed] [Google Scholar]
  • 3.Puchelle E, Bajolet O, Abély M. 2002. Airway mucus in cystic fibrosis. Paediatr Respir Rev 3:115–119. [DOI] [PubMed] [Google Scholar]
  • 4.Du K, Karp PH, Ackerley C, Zabner J, Keshavjee S, Cutz E, Yeger H. 2015. Aggregates of mutant CFTR fragments in airway epithelial cells of CF lungs: New pathologic observations. Journal of Cystic Fibrosis 14:182–193. [DOI] [PubMed] [Google Scholar]
  • 5.Derichs N, Mekus F, Bronsveld I, Bijman J, Veeze HJ, Von Der Hardt H, Tümmler B, Ballmann M. 2003. Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)-mediated residual chloride secretion does not protect against early chronic Pseudomonas aeruginosa infection in F508del homozygous cystic fibrosis patients. Pediatr Res 55:69–75. [DOI] [PubMed] [Google Scholar]
  • 6.Surette MG. 2014. The cystic fibrosis lung microbiome. Ann Am Thorac Soc 11:61–65. [DOI] [PubMed] [Google Scholar]
  • 7.Kiedrowski MR, Bomberger JM. 2018. Viral-bacterial co-infections in the cystic fibrosis respiratory tract. Front Immunol 9:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Burns JL, Gibson RL, McNamara S, Yim D, Emerson J, Rosenfeld M, Hiatt P, McCoy K, Castile R, Smith AL, Ramsey BW. 2001. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis 183:444–452. [DOI] [PubMed] [Google Scholar]
  • 9.Sibley CD, Parkins MD, Rabin HR, Surette MG. 2009. The relevance of the polymicrobial nature of airway infection in the acute and chronic management of patients with cystic fibrosis. Curr Opin Investig Drugs 10:787–794. [PubMed] [Google Scholar]
  • 10.Leclair LW, Hogan DA. 2010. Mixed bacterial-fungal infections in the CF respiratory tract. Med Mycol 48 Suppl 1:125–132. [DOI] [PubMed] [Google Scholar]
  • 11.Rabin HR, Surette MG. 2012. The cystic fibrosis airway microbiome. Curr Opin Pulm Med 18:622–627. [DOI] [PubMed] [Google Scholar]
  • 12.Khanolkar RA, Clark ST, Wang PW, Hwang DM, Yau YCW, Waters VJ, Guttman DS. 2020. Ecological succession of polymicrobial communities in the cystic fibrosis airways. mSystems 5:1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Blanchard AC, Waters VJ. 2022. Opportunistic pathogens in cystic fibrosis: Epidemiology and pathogenesis of lung infection. J Pediatric Infect Dis Soc 11:S3–S12. [DOI] [PubMed] [Google Scholar]
  • 14.Lyczak JB, Cannon CL, Pier GB. 2002. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15:194–222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Short FL, Murdoch SL, Ryan RP. 2014. Polybacterial human disease: The ills of social networking. Trends Microbiol 22:508–516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Peters BM, Jabra-Rizk MA, O’May GA, William Costerton J, Shirtliff ME. 2012. Polymicrobial interactions: impact on pathogenesis and human disease. Clin Microbiol Rev 25:193–213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Brogden KA, Guthmiller JM, Taylor CE. 2005. Human polymicrobial infections. Lancet 365:253–255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Waters VJ, Kidd TJ, Canton R, Ekkelenkamp MB, Johansen HK, Lipuma JJ, Bell SC, Elborn JS, Flume PA, Vandevanter DR, Gilligan P, Bullington W, Burgel PR, Byrnes C, Drevinek P, Holmes A, Kahl B, Maples H, Martiniano S, McColley S, Morris A, Muhlebach M, Parkins M, Ratjen F, Roberts J, Saiman L, Shah A, Smyth A, Somayaji R, Taccetti G, Tunney M, Winthrop K, Zemanick E. 2019. Reconciling antimicrobial susceptibility testing and clinical response in antimicrobial treatment of chronic cystic fibrosis lung infections. Clin Infect Dis 69:1812–1816. [DOI] [PubMed] [Google Scholar]
  • 19.Orazi G, O’Toole GA. 2019. “It Takes a Village”: Mechanisms underlying antimicrobial recalcitrance of polymicrobial biofilms. J Bacteriol 202:1–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Lebeaux D, Ghigo J-M, Beloin C. 2014. Biofilm-related infections: Bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiology and Molecular Biology Reviews 78:510–543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Cornforth DM, Diggle FL, Melvin JA, Bomberger JM, Whiteley M, Casadevall A, Hopkins J. 2020. Quantitative framework for model evaluation in microbiology research using Pseudomonas aeruginosa and cystic fibrosis infection as a test case. mBio 11:1–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Turner KH, Wessel AK, Palmer GC, Murray JL, Whiteley M. 2015. Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum. Proc Natl Acad Sci U S A 112:4110–4115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Palmer KL, Mashburn LM, Singh PK, Whiteley M. 2005. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology. J Bacteriol 187:5267–5277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Jean-Pierre F, Hampton TH, Schultz D, Hogan DA, Groleau M-C, Déziel E, O’Toole GA. 2023. Community composition shapes microbial-specific phenotypes in a cystic fibrosis polymicrobial model system. Elife 12:1–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.DePas WH, Starwalt-Lee R, Van Sambeek L, Kumar SR, Gradinaru V, Newman DK. 2016. Exposing the three-dimensional biogeography and metabolic states of pathogens in cystic fibrosis sputum via hydrogel embedding, clearing, and rRNA labeling. mBio 7:1–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Worlitzsch D, Tarran R, Ulrich M, Schwab U, Cekici A, Meyer KC, Birrer P, Bellon G, Berger J, Weiss T, Botzenhart K, Yankaskas JR, Randell S, Boucher RC, Döring G. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J Clin Invest 109:317–325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Kushner SR. 2004. mRNA decay in prokaryotes and eukaryotes: Different approaches to a similar problem. IUBMB Life 56:585–594. [DOI] [PubMed] [Google Scholar]
  • 28.Laalami S, Putzer H. 2011. MRNA degradation and maturation in prokaryotes: The global players. Biomol Concepts 2:491–506. [DOI] [PubMed] [Google Scholar]
  • 29.Mahat DB, Lis JT. 2017. Use of conditioned media is critical for studies of regulation in response to rapid heat shock. Cell Stress Chaperones 22:155–162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Yus E, Lloréns-Rico V, Martínez S, Gallo C, Eilers H, Blötz C, Stülke J, Lluch-Senar M, Serrano L. 2019. Determination of the gene regulatory network of a genome-reduced bacterium highlights alternative regulation independent of transcription factors. Cell Syst 9:143–158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Cianciulli Sesso A, Lilić B, Amman F, Wolfinger MT, Sonnleitner E, Bläsi U. 2021. Gene expression profiling of Pseudomonas aeruginosa upon exposure to colistin and tobramycin. Front Microbiol 12:1–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Wagner VE, Gillis RJ, Iglewski BH. 2004. Transcriptome analysis of quorum-sensing regulation and virulence factor expression in Pseudomonas aeruginosa. Vaccine 22:15–20. [DOI] [PubMed] [Google Scholar]
  • 33.Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S, Greenberg EP. 2001. Gene expression in Pseudomonas aeruginosa biofilms. Nature 413:860–864. [DOI] [PubMed] [Google Scholar]
  • 34.Schuster M, Lostroh CP, Ogi T, Greenberg EP. 2003. Identification, timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled genes: A transcriptome analysis. J Bacteriol 185:2066–2079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Flynn JM, Niccum D, Dunitz JM, Hunter RC. 2016. Evidence and role for bacterial mucin degradation in cystic fibrosis airway disease. PLoS Pathog 12:1–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Glover JS, Ticer TD, Engevik MA. 2022. Characterizing the mucin-degrading capacity of the human gut microbiota. Sci Rep 12:1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.VanDerHoeven JS, Camp PJM. 1991. Synergistic degradation of mucin by Streptococcus oralis and Streptococcus sanguis in mixed chemostat cultures. J Dent Res 70:1041–1044. [DOI] [PubMed] [Google Scholar]
  • 38.Wickströ C, Herzberg MC, Beighton D, Svensä Ter G. 2009. Proteolytic degradation of human salivary MUC5B by dental biofilms. Microbiology (N Y) 155:2866–2872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Lillehoj EP, Kato K, Lu W, Kim KC. 2013. Cellular and molecular biology of airway mucins. Int Rev Cell Mol Biol 303:139–202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Chatterjee M, van Putten JPM, Strijbis K. 2020. Defensive properties of mucin glycoproteins during respiratory infections—Relevance for SARS-CoV-2. mBio 11:1–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, Wu G, Villanueva J, Wei T, Ausubel FM. 2006. An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A 103:2833–2838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Xu P, Ge X, Chen L, Wang X, Dou Y, Xu JZ, Patel JR, Stone V, Trinh M, Evans K, Kitten T, Bonchev D, Buck GA. 2011. Genome-wide essential gene identification in Streptococcus sanguinis. Sci Rep 1:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, Bayles KW. 2013. A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. mBio 4:1–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Whiteley M, Greenberg EP. 2001. Promoter specificity elements in Pseudomonas aeruginosa quorum-sensing-controlled genes. J Bacteriol 183:5529–5534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Schuster M, Greenberg EP. 2006. A network of networks: Quorum-sensing gene regulation in Pseudomonas aeruginosa. International Journal of Medical Microbiology 296:73–81. [DOI] [PubMed] [Google Scholar]
  • 46.Schuster M, Urbanowski ML, Greenberg EP. 2004. Promoter specificity in Pseudomonas aeruginosa quorum sensing revealed by DNA binding of purified LasR. Proceedings of the National Academy of Science 101:15833–15839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Hennemannid LC, Lafayetteid SL, Maletid JK, Bortolotti P, Yang T, McKayid GA, Houle D, Radziochid D, Rousseauid S, Nguyenid D. 2021. LasR-deficient Pseudomonas aeruginosa variants increase airway epithelial mICAM-1 expression and enhance neutrophilic lung inflammation. PLoS Pathog 17:1–24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, Ramsey BW, Miller SI. 2009. Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. Journal of Cystic Fibrosis 8:66–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Gilbert KB, Kim TH, Gupta R, Greenberg EP, Schuster M. 2009. Global position analysis of the Pseudomonas aeruginosa quorum-sensing transcription factor LasR. Mol Microbiol 73:1072–1085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Illumina. 2021. bcl-convert: a proprietary Illumina software for the conversion of bcl files to basecalls.
  • 51.Martin M. 2011. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J 17:10–12. [Google Scholar]
  • 52.Langmead B, Salzberg SL. 2012. Fast gapped-read alignment with Bowtie 2. Nat Methods 9:357–359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Danecek P, Bonfield JK, Liddle J, Marshall J, Ohan V, Pollard MO, Whitwham A, Keane T, McCarthy SA, Davies RM. 2021. Twelve years of SAMtools and BCFtools. Gigascience 10:1–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Liao Y, Smyth GK, Shi W. 2014. FeatureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30:923–930. [DOI] [PubMed] [Google Scholar]
  • 55.Love MI, Huber W, Anders S. 2014. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:1–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Henry R. 2015. Etymologia: Bonferroni correction. Emerg Infect Dis 21:289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Gu Z, Eils R, Schlesner M. 2016. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics 32:2847–2849. [DOI] [PubMed] [Google Scholar]
  • 58.Kolde R. 2022. Package “pheatmap.”
  • 59.Chen H, Boutros PC. 2011. VennDiagram: A package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics 12:1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Ahlmann-Eltze C. 2020. Combination matrix axis for “ggplot2” to create “UpSet” plots [R package ggupset version 0.3.0].
  • 61.Oksanen J, Blanchet FG, Friendly M, Kindt R, Legendre P, Mcglinn D, Minchin PR, O’hara RB, Simpson GL, Solymos P, Henry M, Stevens H, Szoecs E, Maintainer HW. 2020. Package “vegan” title community ecology package version 2.5–7. R Package Version 26–2. [Google Scholar]
  • 62.Martinez Arbizu P. 2017. pairwiseAdonis: Pairwise multilevel comparison using adonis. R package version 0.0.1. R CRAN.
  • 63.Ahlmann-Eltze C, Patil I. 2021. ggsignif: R Package for Displaying Significance Brackets for “ggplot2” 10.31234/OSF.IO/7AWM6. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1
media-1.xlsx (1.6MB, xlsx)
Supplement 2
media-2.xlsx (716.1KB, xlsx)
Supplement 3
media-3.xlsx (572.1KB, xlsx)
Supplement 4
media-4.xlsx (512KB, xlsx)
Supplement 5
media-5.xlsx (29.7KB, xlsx)
Supplement 6
media-6.xlsx (21.5KB, xlsx)
Supplement 7
media-7.xlsx (15.4KB, xlsx)
Supplement 8
media-8.xlsx (13.8KB, xlsx)
Supplement 9
media-9.xlsx (14.4KB, xlsx)
Supplement 10
media-10.pdf (162.7KB, pdf)

Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES